Home › Funds › FORMULA GROWTH LTD › TOI

FORMULA GROWTH LTD position in TOI

STARLING ONCOLOGY INC

FORMULA GROWTH LTD reported holding 368,400 shares of TOI (STARLING ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 0.90% of its reported portfolio and ranking #28 among its reported holdings. FORMULA GROWTH LTD has disclosed TOI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)368.40K sh
Reported value held$2.33M
Portfolio Weight0.90%
First reportedQ2 2026
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How FORMULA GROWTH LTD's TOI position evolved

FORMULA GROWTH LTD first disclosed a stake in TOI in Q2 2026 at 300,000 shares (US$1.6M). The position peaked in Q3 2026 at 368,400 shares, worth US$2.3M. Across 2 filings, FORMULA GROWTH LTD increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 368,400 shares valued at US$2.3M — an increase of 68,400 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 300.00K $1.63M New
Q3 2026 368.40K $2.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TOI and 13F data

TOI (STARLING ONCOLOGY INC) is a company whose sector is not yet classified in our data. 68 other funds we track also report a position in TOI — the largest reported positions include JOSH ARNOLD INVESTMENT CONSULTANT, LLC (US$13.4M), WEXFORD CAPITAL LP (US$10.8M), BRC Group Holdings, Inc. (US$4.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TOI

All TOI fund holders →

FAQ

How long has FORMULA GROWTH LTD held TOI?

FORMULA GROWTH LTD has disclosed TOI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is FORMULA GROWTH LTD's current position in TOI?

As of Q3 2026, FORMULA GROWTH LTD holds 368.40K shares of TOI (STARLING ONCOLOGY INC), valued at $2.33M, representing 0.90% of its reported portfolio and ranking #28.

Has FORMULA GROWTH LTD been buying or selling TOI?

In the latest 13F filing (Q3 2026), FORMULA GROWTH LTD increased its position in TOI. The position peaked in Q3 2026 at 368.40K shares.

Which other funds hold TOI?

Other major institutional holders of TOI include JOSH ARNOLD INVESTMENT CONSULTANT, LLC, WEXFORD CAPITAL LP, BRC Group Holdings, Inc., among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.